Evidence map›Paper›PMID 29495260›Full record

ArticleMolecules (Basel, Switzerland)2018

Pilot Study of

Lei Jiang, Dongli Song, Hao Chen, Ao Zhang, Huoqiang Wang, Zhen Cheng

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Technology in cancer research & treatment · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Lei JiangDepartment of Nuclear Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. leijiang1031@163.com.
Dongli SongInstitute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai 200032, China. songdongli37@126.com.
Hao ChenMolecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Canary Center at Stanford for Cancer Early Detection, Stanford University, Stanford, CA 94305-5484, USA. haoc@stanford.edu.
Ao ZhangCAS Key Laboratory of Receptor Research, Synthetic Organic & Medicinal Chemistry Laboratory (SOMCL), Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchong Road, Pudong New Area, Shanghai 201203, China. aozhang@simm.ac.cn.ORCID 0000-0001-6642-367X
Huoqiang WangDepartment of Nuclear Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. w2216hq@163.com.
Zhen ChengMolecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Canary Center at Stanford for Cancer Early Detection, Stanford University, Stanford, CA 94305-5484, USA. zcheng@stanford.edu.ORCID 0000-0001-8177-9463
Stanford University · USTongji University · CNChinese Academy of Sciences · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper(II) ion (Cu

Indexed as

Copper RadioisotopesPositron-Emission TomographyAnimalsBiomarkersCation Transport ProteinsCopper Transporter 1Disease Models, AnimalImmunohistochemistryInflammationMalePilot ProjectsPositron Emission Tomography Computed TomographyBiomarkersCation Transport ProteinsCopper-64Copper RadioisotopesCopper Transporter 164CuCl2copper transporter 1 (CTR1)inflammationPET

Identifiers

PMID29495260
PMCPMC6017813
OpenAlexW2792035519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.